Several batches of the drug metformin tested positive for a chemical that likely contributes to cancer. The announcement late Thursday follows dozens of heartburn drug recalls in the last year linked to the same contaminant.
By Matthew Perrone, Associated Press
Medicare recipients will be able to get prescription plans that limit copays for insulin, a potential savings of hundreds of dollars, the White House announced Tuesday in a pivot to pocketbook issues that could influence November's election.
By Ricardo Alonso-Zaldivar, Associated Press
Insulin is a vital drug that some 7.4 million Americans must take daily to manage their diabetes. But its price nearly doubled from 2012 to 2016, leaving some patients with no choice but to turn to black-market drugs or traveling…
By Sarah Varney
Obesity could be in your future — and this $50 genetic test can predict your risk.
By Vicky Stein
By Bram Sable-Smith, Side Effects Public Media
The price of insulin in the U.S. has more than doubled since 2012 alone. That’s put the lifesaving hormone out of reach for some people with diabetes.
By Laura Santhanam
A recent study highlights how complicated childhood obesity continues to be, as the United States scrambles to address one of the greatest risk factors for chronic illness, including diabetes, cancer and heart disease, later in life.
A national network of clinics claims it offers a miraculous procedure to treat diabetes, but many in the medical community are not convinced. Special correspondent Cheryl Clark from inewsource tells the story of a couple in rural Montana who believed…
Most adults say they struggle with remembering to take their prescriptions. A nationwide study is testing a pill with an ingestible sensor that tracks medication adherence from inside the body.
By Philip Moeller
Medicare is beginning in April to expand diabetes education and prevention efforts and will pay all expenses of people who qualify for the program. Plus, your Medicare card is about to change.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.